Qualio

Executive Summary

Qualio is a San Francisco-based provider of a unified Quality Management System (QMS) and compliance intelligence platform tailored for life sciences companies. Founded in 2012, the company addresses a critical pain point in regulated industries: preparing for audits. By integrating QMS, design controls, and compliance intelligence, Qualio automates gap analysis across 28+ regulatory standards, including FDA, ISO 13485, and EU MDR. This reduces audit preparation time from over 20 weeks to under 4 weeks, enabling continuous audit-readiness. The platform serves medical device, pharmaceutical, and biotechnology firms, offering a SaaS solution that combines document control, training management, and compliance monitoring in one system. Qualio's value proposition is particularly compelling as regulatory scrutiny intensifies and companies seek to minimize downtime and costs associated with audits and inspections.

Upcoming Catalysts (preview)

• Q3 2026FDA's anticipated final rule on Quality Management System Regulation (QMSR) integration with ISO 1348580% success
• TBDExpansion of automated MDR compliance module to cover additional EU member state requirements70% success
• H2 2026Potential Series C funding round to accelerate AI-driven compliance analytics capabilities60% success